Markku Kaste

59.7k total citations · 10 hit papers
367 papers, 34.7k citations indexed

About

Markku Kaste is a scholar working on Epidemiology, Pulmonary and Respiratory Medicine and Neurology. According to data from OpenAlex, Markku Kaste has authored 367 papers receiving a total of 34.7k indexed citations (citations by other indexed papers that have themselves been cited), including 223 papers in Epidemiology, 117 papers in Pulmonary and Respiratory Medicine and 115 papers in Neurology. Recurrent topics in Markku Kaste's work include Acute Ischemic Stroke Management (208 papers), Cerebrovascular and Carotid Artery Diseases (107 papers) and Stroke Rehabilitation and Recovery (81 papers). Markku Kaste is often cited by papers focused on Acute Ischemic Stroke Management (208 papers), Cerebrovascular and Carotid Artery Diseases (107 papers) and Stroke Rehabilitation and Recovery (81 papers). Markku Kaste collaborates with scholars based in Finland, United States and Germany. Markku Kaste's co-authors include Werner Hacke, Kennedy R. Lees, Erich Bluhmki, Danilo Toni, Turgut Tatlisumak, Antoni Dávalos, Rüdiger von Kummer, Vincent Larrue, Tarja Pohjasvaara and Dietmar Schneider and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Markku Kaste

355 papers receiving 33.3k citations

Hit Papers

Thrombolysis with Alteplase 3 to 4.5 Hours after A... 1995 2026 2005 2015 2008 1998 2007 2010 2004 1000 2.0k 3.0k 4.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke
    2008 4.7k citations Werner Hacke, Markku Kaste et al. profile →
  2. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II)
    1998 2.6k citations Werner Hacke, Markku Kaste et al. profile →
  3. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study
    2007 1.6k citations Nils Wahlgren, Niaz Ahmed et al. profile →
  4. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials
    2010 1.6k citations Kennedy R. Lees, James C. Grotta et al. profile →
  5. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial
    2004 1.4k citations Julien Bogousslavsky, Markku Kaste et al. profile →
  6. The Desmoteplase in Acute Ischemic Stroke Trial (DIAS)
    2004 758 citations Werner Hacke, Julien Bogousslavsky et al. Stroke profile →
  7. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)
    1995 712 citations Werner Hacke, Markku Kaste et al. profile →
  8. Analysis of 1008 Consecutive Patients Aged 15 to 49 With First-Ever Ischemic Stroke
    2009 547 citations Jukka Putaala, Markku Kaste et al. Stroke profile →
  9. Reducing in-hospital delay to 20 minutes in stroke thrombolysis
    2012 397 citations Atte Meretoja, Daniel Strbian et al. profile →
  10. Post‐stroke cognitive impairment is common even after successful clinical recovery
    2015 316 citations Markku Kaste et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Markku Kaste Finland 87 22.9k 10.5k 9.8k 9.0k 6.2k 367 34.7k
Geoffrey A. Donnan Australia 94 21.6k 0.9× 10.5k 1.0× 10.4k 1.1× 8.4k 0.9× 4.2k 0.7× 652 37.5k
José Biller United States 55 18.0k 0.8× 9.2k 0.9× 10.9k 1.1× 5.8k 0.6× 3.9k 0.6× 297 30.2k
Harold P. Adams United States 65 24.6k 1.1× 15.6k 1.5× 15.1k 1.5× 7.3k 0.8× 5.3k 0.9× 255 41.1k
Kennedy R. Lees United Kingdom 71 18.0k 0.8× 7.7k 0.7× 7.1k 0.7× 6.5k 0.7× 4.8k 0.8× 324 26.7k
Joseph P. Broderick United States 97 22.3k 1.0× 18.3k 1.7× 8.2k 0.8× 5.9k 0.7× 4.0k 0.6× 363 36.0k
James C. Grotta United States 94 18.3k 0.8× 11.3k 1.1× 7.9k 0.8× 6.5k 0.7× 4.6k 0.7× 456 29.9k
Eric E. Smith Canada 96 16.2k 0.7× 10.8k 1.0× 5.3k 0.5× 5.5k 0.6× 4.2k 0.7× 646 32.0k
Peter Sandercock United Kingdom 83 13.9k 0.6× 7.6k 0.7× 7.6k 0.8× 4.3k 0.5× 2.8k 0.5× 322 24.8k
Gregory W. Albers United States 101 25.2k 1.1× 11.4k 1.1× 15.8k 1.6× 5.6k 0.6× 8.1k 1.3× 568 39.1k
Werner Hacke Germany 89 32.9k 1.4× 17.6k 1.7× 15.9k 1.6× 9.8k 1.1× 8.4k 1.3× 389 43.4k

Countries citing papers authored by Markku Kaste

Since Specialization
Citations

This map shows the geographic impact of Markku Kaste's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markku Kaste with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markku Kaste more than expected).

Fields of papers citing papers by Markku Kaste

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markku Kaste. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markku Kaste. The network helps show where Markku Kaste may publish in the future.

Co-authorship network of co-authors of Markku Kaste

This figure shows the co-authorship network connecting the top 25 collaborators of Markku Kaste. A scholar is included among the top collaborators of Markku Kaste based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markku Kaste. Markku Kaste is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vuorio, Alpo, Frederick J. Raal, Markku Kaste, & Petri T. Kovanen. (2021). Familial hypercholesterolaemia and COVID-19: A two-hit scenario for endothelial dysfunction amenable to treatment. Atherosclerosis. 320. 53–60. 20 indexed citations
2.
Aarnio, Karoliina, Nicolas Martinez‐Majander, Juha Sinisalo, et al.. (2018). Use of antihypertensive medication after ischemic stroke in young adults and its association with long-term outcome. Annals of Medicine. 51(1). 68–77. 12 indexed citations
3.
Meretoja, Atte, Mahsa Keshtkaran, Jeffrey L. Saver, et al.. (2014). Stroke Thrombolysis. Stroke. 45(4). 1053–1058. 236 indexed citations
4.
Sairanen, Tiina, Daniel Strbian, Lauri Soinne, et al.. (2011). Intravenous Thrombolysis of Basilar Artery Occlusion. Stroke. 42(8). 2175–2179. 73 indexed citations
5.
Meretoja, Atte, Markku Kaste, Risto O. Roine, et al.. (2011). Trends in treatment and outcome of stroke patients in Finland from 1999 to 2007. PERFECT Stroke, a nationwide register study. Annals of Medicine. 43(sup1). S22–S30. 42 indexed citations
6.
Meretoja, Atte, Risto O. Roine, Markku Kaste, et al.. (2010). Effectiveness of Primary and Comprehensive Stroke Centers. Stroke. 41(6). 1102–1107. 107 indexed citations
7.
Mustanoja, Satu, Atte Meretoja, Jukka Putaala, et al.. (2010). Outcome by Stroke Etiology in Patients Receiving Thrombolytic Treatment. Stroke. 42(1). 102–106. 78 indexed citations
8.
Mishra, Nishant K., Kennedy R. Lees, Nils Wahlgren, et al.. (2010). 5th UK Stroke Forum Conference 30 November-2 December 2010 SECC, Glasgow, UK Abstracts. ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam). 1 indexed citations
9.
Berg, Anu, Jouko Lönnqvist, Heikki Palomäki, & Markku Kaste. (2008). Assessment of Depression After Stroke. Stroke. 40(2). 523–529. 138 indexed citations
10.
Ringelstein, E. Bernd, et al.. (2008). European Stroke Facilities Survey: The German and Austrian Perspective. Cerebrovascular Diseases. 27(2). 138–145. 22 indexed citations
11.
Leys, Didier, E. Bernd Ringelstein, Markku Kaste, & Werner Hacke. (2007). The Main Components of Stroke Unit Care: Answer to Dr. Peter Langhorne’s Comments. Cerebrovascular Diseases. 23(5-6). 465–465. 3 indexed citations
12.
Soinne, Lauri, Eija Saimanen, Petri T. Kovanen, et al.. (2005). Association of the Fibrinolytic System and Hemorheology with Symptoms in Patients with Carotid Occlusive Disease. Cerebrovascular Diseases. 20(3). 172–179. 11 indexed citations
13.
Lindsberg, Perttu J. & Markku Kaste. (2003). Thrombolysis for acute stroke. Current Opinion in Neurology. 16(1). 73–80. 17 indexed citations
14.
Kaste, Markku. (2003). Approval of alteplase in Europe: will it change stroke management?. The Lancet Neurology. 2(4). 207–208. 23 indexed citations
15.
Hillbom, Matti, T. Erilä, K. A. Sotaniemi, et al.. (2002). Enoxaparin vs heparin for prevention of deep-vein thrombosis in acute ischaemic stroke: a randomized, double-blind study. Acta Neurologica Scandinavica. 106(2). 84–92. 96 indexed citations
16.
Hacke, Werner, Markku Kaste, Tom Skyhøj Olsen, Julien Bogousslavsky, & Jean‐Marc Orgogozo. (2000). Acute Treatment of Ischemic Stroke. Cerebrovascular Diseases. 10(Suppl. 3). 22–33. 77 indexed citations
17.
Muuronen, Antti, Markku Kaste, E Nikkilä, & E.‐M. Tolppanen. (1985). Mortality from ischaemic heart disease among patients using anticonvulsive drugs: a case-control study.. BMJ. 291(6507). 1481–1483. 63 indexed citations
18.
Kaste, Markku, Matti Hillbom, & J. Palo. (1979). Diagnosis and management of brain death.. BMJ. 1(6162). 525–527. 13 indexed citations
19.
Nikkilä, E, Markku Kaste, Christian Ehnholm, & Jorma Viikari. (1978). Increase of serum high-density lipoprotein in phenytoin users.. BMJ. 2(6130). 99–99. 67 indexed citations
20.
Kaste, Markku, R Fogelholm, & O. Waltimo. (1976). Combined dexamethasone and low-molecular-weight dextran in acute brain infarction: double-blind study.. BMJ. 2(6049). 1409–1410. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Geoffrey A. Donnan Breakdown of academic impact, for papers by José Biller Breakdown of academic impact, for papers by Harold P. Adams Breakdown of academic impact, for papers by Kennedy R. Lees Breakdown of academic impact, for papers by Joseph P. Broderick Breakdown of academic impact, for papers by James C. Grotta Breakdown of academic impact, for papers by Eric E. Smith Breakdown of academic impact, for papers by Peter Sandercock Breakdown of academic impact, for papers by Gregory W. Albers Breakdown of academic impact, for papers by Werner Hacke
Rankless by CCL
2026